Zydus Cadila - Company & Market Research Reports

Zydus Cadila Pharmaceutical is a global healthcare provider. The origins of this group go back to 1952, however in 1995 this group restructured its operations and the Cadila group were taken over by the Zydus group. It is the only Indian pharma company to launch its own patented NCE. They developed a drug for diabetic dyslipidemia, Lipaglyn. This is the first drug to be approved for this disease. They are the 4th largest in the Indian pharma market. Other than their successful sales from India, Zydus gains a wider market share through its subsidiaries in the U.S, Europe (France and Spain), South Africa and Latin America. From their beginning in 1995 to today Zydus has shown major growth rates in revenue.


Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMs), Biosimilars, Generics & Vaccines - Product Thumbnail Image

Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMs), Biosimilars, Generics & Vaccines

  • Report
  • 183 Pages
From
Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016 - Product Thumbnail Image

Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016

  • Report
  • 62 Pages
From
Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2016 - Product Thumbnail Image

Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2016

  • Report
  • 70 Pages
From
Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2015 - Product Thumbnail Image

Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2015

  • Report
  • 77 Pages
From
Humira Biosimilars Clinical Trial Insight - Product Thumbnail Image

Humira Biosimilars Clinical Trial Insight

  • Clinical Trials
  • 80 Pages
From
Human Papillomavirus Infections - Pipeline Review, H2 2015 - Product Thumbnail Image

Human Papillomavirus Infections - Pipeline Review, H2 2015

  • Report
  • 164 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017

  • Report
  • 919 Pages
From
Hepatitis Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2017

  • Report
  • 209 Pages
From
2018 Gastritis (stomach inflammation) Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Gastritis (stomach inflammation) Drug Development- Pipeline Analysis Report

  • Report
  • 40 Pages
From
PDE Inhibitors Market, 2016-2026 - Product Thumbnail Image

PDE Inhibitors Market, 2016-2026

  • Report
  • 223 Pages
From
Lifestyle Drugs Market: By Disease & By Region - Forecast 2016-2021 - Product Thumbnail Image

Lifestyle Drugs Market: By Disease & By Region - Forecast 2016-2021

  • Report
  • 132 Pages
From
2018 Post Operative Nausea And Vomiting Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Post Operative Nausea And Vomiting Drug Development- Pipeline Analysis Report

  • Report
  • 40 Pages
From
Hepatitis A - Pipeline Insight, 2018 - Product Thumbnail Image

Hepatitis A - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Global Generic Drugs Market 2016-2020 - Product Thumbnail Image

Global Generic Drugs Market 2016-2020

  • Report
  • 111 Pages
From
Branded Generics Market: By Type; By Applications:; By Distribution; By Geography & Forecast - Forecast 2016 -2021 - Product Thumbnail Image

Branded Generics Market: By Type; By Applications:; By Distribution; By Geography & Forecast - Forecast 2016 -2021

  • Report
  • 150 Pages
From
Global Generic Drug Litigation Updates 2018: Opportunities for Generic Companies Based on the Latest Para IV Events - Product Thumbnail Image

Global Generic Drug Litigation Updates 2018: Opportunities for Generic Companies Based on the Latest Para IV Events

  • Report
Important Para IV Events - Product Thumbnail Image

Important Para IV Events

  • Report
Indian Generic Drug Market Outlook 2020 - Product Thumbnail Image

Indian Generic Drug Market Outlook 2020

  • Report
  • 90 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update

  • Report
  • 124 Pages
From
Loading Indicator
adroll